Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Real-world Experience with Ipilimumab in Combination with Nivolumab in Advanced Sarcoma: A Retrospective Analysis Including Ultra-Rare Sarcomas.
Journal: The oncologist
Published: May 05, 2026
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Journal: Cancer medicine
Published: November 03, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Journal: The oncologist
Published: June 21, 2020
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.
Journal: Cancer medicine
Published: September 06, 2019
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 24, 2019
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
Journal: JAMA oncology
Published: May 01, 2018
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Journal: Gynecologic oncology
Published: April 28, 2017
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors.
Journal: Sarcoma
Published: April 14, 2017
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
Journal: Cancer
Published: April 29, 2016
Last Updated: 09/26/2026